MedTrace Logo

PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

NCT00471289 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2020-09-16

No results posted yet for this study

Summary

The purpose of this study is to investigate the performance of paclitaxel-coated balloon expandable stainless steel coronary stent for the treatment of infrapopliteal stenoses and occlusions in patients with critical limb ischemia compared to percutaneous transluminal balloon angioplasty (PTA).

Conditions

  • Peripheral Vascular Disease

Interventions

DEVICE

PTA with placement of paclitaxel-eluting stent

PTA with placement of paclitaxel-eluting stent

DEVICE

PTA

PTA

Sponsors & Collaborators

  • Netherlands Society for Interventional Radiology

    lead OTHER

Principal Investigators

  • Hans Van Overhagen, MD PhD · HagaZiekenhuis Dept. of Radiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2013-09-30
Completion
2023-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471289 on ClinicalTrials.gov